PR Newswire Europe - Eurand Receives Approval To Market Generic Sodium Diclofenac.
MILAN, Italy, October 25 /PRNewswire/ — Eurand today announced that it has received final approval from the Medicines and Healthcare Regulatory Agency (MHRA) in the United Kingdom (UK) for its Application for Sodium Diclofenac 75mg and 100mg modified release capsules. Sodium Diclofenac modified release is the generic version of Voltarol(R), a Novartis product.
Most Popular
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
Business Plan Sample
Sodium Diclofenac is used to treat all levels of pain and inflammation in a wide variety of conditions. The market for sodium Diclofenac in the UK is approximately Stg 90 million (US$130M). Theapproved product will be …
Read the rest of this article with a Free Trial at HighBeam Research.
